By Dean Seal


Shares of Rapid Micro Biosystems rose after the company said its Growth Direct platform has been selected by Samsung Biologics for the automation of microbial quality control processes.

The stock was up 9% at 98 cents in recent trading. Shares were trading at around $1.38 a year ago.

The life-sciences technology company said before the bell on Thursday that Samsung Biologics picked the platform to help increase efficiency and deliver more robust data integrity as well as scalable quality control operations.

No further details about the arrangement were given.


Write to Dean Seal at dean.seal@wsj.com


(END) Dow Jones Newswires

01-04-24 1006ET